Clue
PrivateLast Round
Strategic
Jan 15, 2026
Est. Valuation
$73.89M
Total Funding Raised
$31.87M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Clue operates in Healthcare & Life Sciences and is based in Berlin. Its latest recorded funding round was a Strategic round in January 2026.
Clue is a femtech company that develops a mobile application for tracking menstrual and fertility cycles, providing users with data-driven insights into their reproductive health.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Healthcare Analytics, Subscription Commerce
Business Model
B2C
Customer Profile
Subscription SaaS, Freemium
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Clue Comparables
Compare Clue with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Flo Health | 89% | |
| Natural Cycles | 89% | |
| Glow | 80% |
For institutional investors. Book with your work email.
Clue Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jan 15, 2026 | ||||
| Crowdfunding | May 11, 2023 | ||||
| VC Round | Apr 3, 2023 | ||||
| VC Round | Dec 16, 2021 | ||||
| Series B | Nov 30, 2016 | ||||
Series A | Oct 9, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Clue Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Union Square Ventures | VC Round, Crowdfunding, Series B, Series A |
| Adjacent | VC Round |
| The Washington Medical Technology Angel Network | Series B |
| Mosaic Ventures | Series B, Series A |
| Financière Agache | Seed, Series A |
| FJ Labs | Series B |
| Giving Wings | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 13, 2026
Surpassed 10 million monthly users.
- Jan 24, 2026
Collaborating with Stanford University and Oxford University.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesNov 1, 2026
In 2021, Clue receives FDA 510(k) clearance to launch Clue Birth Control, an all-digital contraceptive that relies on period-tracking data.
- partners_withOct 14, 2026
Clue and Plan Your Baby Ltd partner as part of a vetted provider network supporting Clue's Get Care initiative, which connects users with women's health care providers across the United States, the United Kingdom, and Germany.
- partners_withOct 14, 2026
Clue partners with Navicare as part of Clue's network of vetted providers for its free Get Care initiative, which connects users with women's health care providers across the United States, the United Kingdom, and Germany.
- partners_withOct 8, 2026
Clue is working with Novo Nordisk A/S to help women understand their metabolic health, including during perimenopause, and access information and care.
- launchesOct 8, 2026
Clue launches the free 'Get Care' initiative in Germany on Oct 8th '26, connecting users from within its app directly to trusted care providers across contraception, conception, metabolic and mental health, perimenopause, and at-home testing.
For institutional investors. Book with your work email.
Clue Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Clue's valuation, stock price, and market status.
Is Clue a public or private company?
Clue is a private company.
What is the current stock price of Clue?
Clue is a private company, so its shares have no public market price. Caplight tracks Clue's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Clue worth (valuation)?
Clue's valuation is estimated at $73.9M based on funding round data.
Can I buy Clue stock?
Clue shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Clue's last funding round?
Clue's most recent funding round was Strategic on January 15, 2026.
Who are the main investors in Clue?
Key investors in Clue include Union Square Ventures, Mosaic Ventures, Future Positive Capital, Balderton Capital, NGP Capital.
Will Clue IPO soon?
No public IPO plans have been announced for Clue.
How can I track Clue secondary market activity?
Caplight tracks bids, offers, and trades in Clue's shares on secondary markets.